From the list, seven candidate AD‐specific autoantibodies were identified, including MAPT, DNAJC8, KDM4D, SERF1A, CDKN1A, AGER, and ASXL1 (Table S2, Table 5).113. This evidence concerns the gene MAPT and Alzheimer disease.